Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines

被引:30
作者
Dhawan, Manish [1 ,2 ]
Rabaan, Ali A. [3 ,4 ,5 ]
Al Fawarah, Mahmoud M. [6 ]
Almuthree, Souad A. [7 ]
Alsubki, Roua A. [8 ]
Alfaraj, Amal H. [9 ]
Mashraqi, Mutaib M. [10 ]
Alshamrani, Saleh A. [10 ]
Abduljabbar, Wesam A. [11 ]
Alwashmi, Ameen S. S. [12 ]
Al Ibrahim, Fatimah [13 ]
Alsaleh, Abdulmonem A. [14 ]
Khamis, Faryal [15 ]
Alsalman, Jameela [16 ]
Sharma, Manish [17 ]
Bin Emran, Talha [18 ,19 ]
机构
[1] Punjab Agr Univ, Dept Microbiol, Ludhiana 141004, Punjab, India
[2] Trafford Coll, Manchester WA14 5PQ, England
[3] Johns Hopkins Aramco Healthcare, Mol Diagnost Lab, Dhahran 31311, Saudi Arabia
[4] Alfaisal Univ, Coll Med, Riyadh 11533, Saudi Arabia
[5] Univ Haripur, Dept Publ Hlth & Nutr, Haripur 22610, Pakistan
[6] Johns Hopkins Aramco Healthcare, Microbiol Lab, Dhahran 31311, Saudi Arabia
[7] King Abdullah Med City, Dept Infect Dis, Mecca 43442, Saudi Arabia
[8] King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh 11362, Saudi Arabia
[9] Abqaiq Gen Hosp, Pediat Dept, Eastern Hlth Cluster 1, Abqaiq 33261, Saudi Arabia
[10] Najran Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Najran 61441, Saudi Arabia
[11] Fakeeh Coll Med Sci, Dept Med Lab Sci, Jeddah 21134, Saudi Arabia
[12] Qassim Univ, Coll Appl Med Sci, Dept Med Labs, Buraydah 51452, Saudi Arabia
[13] Dammam Med Complex, Dept Internal Med, Infect Dis Div, Dammam 32245, Saudi Arabia
[14] Mohammed Al Mana Coll Med Sci, Clin Lab Sci Dept, Dammam 34222, Saudi Arabia
[15] Royal Hosp, Dept Internal Med, Infect Dis Unit, Muscat 1331, Oman
[16] Minist Hlth, Dept Internal Med, Infect Dis Unit, Salmaniya Med Complex, Manama 435, Bahrain
[17] Chandigarh Univ, Univ Inst Biotechnol, Dept Biotechnol, Mohali 140413, Punjab, India
[18] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4381, Bangladesh
[19] Daffodil Int Univ, Fac Allied Hlth Sci, Dept Pharm, Dhaka 1207, Bangladesh
关键词
COVID-19; immune response; SARS-CoV-2; T cells; T-cells' exhaustion; Therapeutics; vaccines; CHRONIC VIRAL-INFECTION; SEVERE COVID-19; OMICRON VARIANT; SPIKE PROTEIN; LYMPHOCYTES; MECHANISMS; REACTIVITY; CLEARANCE; RECOVERY; BLOCKADE;
D O I
10.3390/vaccines11010101
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune response elicited through presently available vaccination makes it essential to recognize the mechanisms through which SARS-CoV-2 interacts with the human immune response. It is essential not only to comprehend the infection mechanism of SARS-CoV-2 but also for the generation of effective and reliable vaccines against COVID-19. The effectiveness of the vaccine is supported by the adaptive immune response, which mainly consists of B and T cells, which play a critical role in deciding the prognosis of the COVID-19 disease. T cells are essential for reducing the viral load and containing the infection. A plethora of viral proteins can be recognized by T cells and provide a broad range of protection, especially amid the emergence of novel variants of SARS-CoV-2. However, the hyperactivation of the effector T cells and reduced number of lymphocytes have been found to be the key characteristics of the severe disease. Notably, excessive T cell activation may cause acute respiratory distress syndrome (ARDS) by producing unwarranted and excessive amounts of cytokines and chemokines. Nevertheless, it is still unknown how T-cell-mediated immune responses function in determining the prognosis of SARS-CoV-2 infection. Additionally, it is unknown how the functional perturbations in the T cells lead to the severe form of the disease and to reduced protection not only against SARS-CoV-2 but many other viral infections. Hence, an updated review has been developed to understand the involvement of T cells in the infection mechanism, which in turn determines the prognosis of the disease. Importantly, we have also focused on the T cells' exhaustion under certain conditions and how these functional perturbations can be modulated for an effective immune response against SARS-CoV-2. Additionally, a range of therapeutic strategies has been discussed that can elevate the T cell-mediated immune response either directly or indirectly.
引用
收藏
页数:28
相关论文
共 198 条
[1]   Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection [J].
Adamo, Sarah ;
Michler, Jan ;
Zurbuchen, Yves ;
Cervia, Carlo ;
Taeschler, Patrick ;
Raeber, Miro E. ;
Sain, Simona Baghai ;
Nilsson, Jakob ;
Moor, Andreas E. ;
Boyman, Onur .
NATURE, 2022, 602 (7895) :148-+
[2]   Identification of Potential SARS-CoV-2 CD8+ T Cell Escape Mutants [J].
Ahmed, Syed Faraz ;
Sohail, Muhammad Saqib ;
Quadeer, Ahmed Abdul ;
McKay, Matthew R. .
VACCINES, 2022, 10 (04)
[3]   SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron [J].
Ahmed, Syed Faraz ;
Quadeer, Ahmed Abdul ;
McKay, Matthew R. .
VIRUSES-BASEL, 2022, 14 (01)
[4]   Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis [J].
Akbar, Mohammad Rizki ;
Wibowo, Arief ;
Pranata, Raymond ;
Setiabudiawan, Budi .
FRONTIERS IN NUTRITION, 2021, 8
[5]   Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19 [J].
Angelopoulou, Athina ;
Alexandris, Nikos ;
Konstantinou, Evangelia ;
Mesiakaris, Konstantinos ;
Zanidis, Charilaos ;
Farsalinos, Konstantinos ;
Poulas, Konstantinos .
ENVIRONMENTAL RESEARCH, 2020, 188
[6]   NKG2A and COVID-19: another brick in the wall [J].
Antonioli, Luca ;
Fornai, Matteo ;
Pellegrini, Carolina ;
Blandizzi, Corrado .
CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (06) :672-674
[7]   Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers [J].
Antunes, Ricardo da Silva ;
Pallikkuth, Suresh ;
Williams, Erin ;
Yu, Esther Dawen ;
Mateus, Jose ;
Quiambao, Lorenzo ;
Wang, Eric ;
Rawlings, Stephen A. ;
Stadlbauer, Daniel ;
Jiang, Kaijun ;
Amanat, Fatima ;
Arnold, David ;
Andrews, David ;
Fuego, Irma ;
Dan, Jennifer M. ;
Grifoni, Alba ;
Weiskopf, Daniela ;
Krammer, Florian ;
Crotty, Shane ;
Hoffer, Michael E. ;
Pahwa, Savita G. ;
Sette, Alessandro .
JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (01) :70-80
[8]   interleukin-2: Biology, Design and Application [J].
Arenas-Ramirez, Natalia ;
Woytschak, Janine ;
Boyman, Onur .
TRENDS IN IMMUNOLOGY, 2015, 36 (12) :763-777
[9]   Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans [J].
Arunachalam, Prabhu S. ;
Wimmers, Florian ;
Mok, Chris Ka Pun ;
Perera, Ranawaka A. P. M. ;
Scott, Madeleine ;
Hagan, Thomas ;
Sigal, Natalia ;
Feng, Yupeng ;
Bristow, Laurel ;
Tsang, Owen Tak-Yin ;
Wagh, Dhananjay ;
Coller, John ;
Pellegrini, Kathryn L. ;
Kazmin, Dmitri ;
Alaaeddine, Ghina ;
Leung, Wai Shing ;
Chan, Jacky Man Chun ;
Chik, Thomas Shiu Hong ;
Choi, Chris Yau Chung ;
Huerta, Christopher ;
McCullough, Michele Paine ;
Lv, Huibin ;
Anderson, Evan ;
Edupuganti, Srilatha ;
Upadhyay, Amit A. ;
Bosinger, Steve E. ;
Maecker, Holden Terry ;
Khatri, Purvesh ;
Rouphael, Nadine ;
Peiris, Malik ;
Pulendran, Bali .
SCIENCE, 2020, 369 (6508) :1210-+
[10]   Homologous and Heterologous Covid-19 Booster Vaccinations [J].
Atmar, R. L. ;
Lyke, K. E. ;
Deming, M. E. ;
Jackson, L. A. ;
Branche, A. R. ;
El Sahly, H. M. ;
Rostad, C. A. ;
Martin, J. M. ;
Johnston, C. ;
Rupp, R. E. ;
Mulligan, M. J. ;
Brady, R. C. ;
Frenck, R. W., Jr. ;
Backer, M. ;
Kottkamp, A. C. ;
Babu, T. M. ;
Rajakumar, K. ;
Edupuganti, S. ;
Dobrzynski, D. ;
Coler, R. N. ;
Posavad, C. M. ;
Archer, J., I ;
Crandon, S. ;
Nayak, S. U. ;
Szydlo, D. ;
Zemanek, J. A. ;
Islas, C. P. Dominguez ;
Brown, E. R. ;
Suthar, M. S. ;
McElrath, M. J. ;
McDermott, A. B. ;
Montefiori, D. C. ;
Eaton, A. ;
Neuzil, K. M. ;
Stephens, D. S. ;
Roberts, P. C. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11) :1046-1057